Suppr超能文献

药剂师对紧急治疗或续方配药的补贴以及新冠疫情的影响:多州法律审查

Pharmacist Allowances for the Dispensing of Emergency or Continuation of Therapy Prescription Refills and the COVID-19 Impact: A Multistate Legal Review.

作者信息

DeRosa Nicholas, Leung Ka, Vlahopoulos Julia, Lavino Joseph

机构信息

Massachusetts College of Pharmacy and Health Sciences University.

出版信息

Innov Pharm. 2021 Jun 10;12(3). doi: 10.24926/iip.v12i3.4222. eCollection 2021.

Abstract

The COVID-19 pandemic has taught Americans many lessons, including what can happen when our healthcare system is strained. During the pandemic, certain healthcare related activities such as seeing or contacting a practitioner to receive a prescription refill may have been a challenge for some patients that could have interfered in the patient's medication adherence and continuity of care. Given these circumstances, the pandemic also shed light on the necessity for pharmacists to dispense emergency refills, which often is based on variable state pharmacy laws and regulations. State pharmacy laws and regulations vary from allowing pharmacists to dispense as much medication that is required for the patient to receive a new prescription to emergency refills being allowed only in the direst situations to save a patient's life. State pharmacy laws and regulations vary in the allowable quantities that may be dispensed, the federal schedule of controlled substance medications, and the circumstances they can be dispensed. In many cases, COVID-19 emergency regulations, governor executive orders and board of pharmacy guidance have expanded the authority for a pharmacist to dispense emergency refills. However, these allowances are often finite in nature and would end when the pandemic state of emergency ends. This paper seeks to analyze the laws and regulations in each state pertaining to the ability of a pharmacist to dispense an emergency refill when a patient's prescription does not have refills and provide a recommendation to optimize the state legal and regulatory landscape to expand current allowances.

摘要

新冠疫情给美国人上了很多课,包括当我们的医疗系统不堪重负时会发生什么。在疫情期间,某些与医疗保健相关的活动,比如看医生或联系医生以获取处方续药,对一些患者来说可能是一项挑战,这可能会干扰患者的用药依从性和护理的连续性。鉴于这些情况,疫情也凸显了药剂师发放紧急续药的必要性,而这通常取决于各州不同的药房法律法规。各州的药房法律法规各不相同,从允许药剂师发放患者获取新处方所需的足量药物,到仅在最危急的情况下允许紧急续药以挽救患者生命。各州的药房法律法规在可发放的允许数量、联邦管制物质药物清单以及可发放的情形方面都有所不同。在许多情况下,新冠疫情紧急法规、州长行政命令和药房委员会指南扩大了药剂师发放紧急续药的权限。然而,这些许可往往是有限的,会在疫情紧急状态结束时终止。本文旨在分析每个州关于药剂师在患者处方没有续药时发放紧急续药能力的法律法规,并提出优化州法律和监管环境以扩大当前许可的建议。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验